About Grey Wolf Therapeutics
Novel antigen modulation technology that controls T cells to guide the immune system
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Abingdon, United Kingdom
Year Founded
2017
Team Size
51-100
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
greywolftherapeutics.com
Domain Registered Date
Sep 6, 2017
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $50,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $49,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-A announced
- Milestone
X account created (@GreywolfHQ)
4 followers
- Milestone
Website domain registered
greywolftherapeutics.com
- Milestone
Company founded
Abingdon, United Kingdom
Investors & Backers
Andera Partners
British Patient Capital
Canaan Partners
Earlybird VC
Intermediate Capital Group
Oxford Science Enterprises
Pfizer Venture Investments
Funding History
Series-B+
· May 23, 2024
$50,000,000 fundraisingfox.com
Series-B+
· Jan 26, 2023
$49,000,000 fundraisingfox.com
Series-A
· Feb 11, 2019
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
fundraisingfox.com
fundraisingfox.com/companies/grey-wolf-therapeutics
globenewswire.com
globenewswire.com/news-release/2019/02/11/1716301/0/en/Grey-Wolf-Therapeutics-completes-10-million-14-million-series-A-financing-with-Andera-Partners-and-Canaan-to-fund-development-of-immuno-oncology-therapies-to-increase-tumour-visibi.html
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026